genetics

Pharmalot By Ed Silverman

Citing competitive concerns, European Commission seeks to intervene in Illumina’s $8 billion acquisition of Grail

Biotech By Matthew Herper and Damian Garde

STAT+ Conversation: What’s next in gene therapy

Biotech By Matthew Herper and Megan Molteni

Return of the mammoth? George Church-backed company launches with $15 million for elephant-sized quest

Biotech By Kate Sheridan

In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching

In the Lab By Theresa Gaffney

Never-smokers’ lung cancers are genetically different from smokers’ tumors, study shows

Health By Andrew Joseph

Can parents handle finding out their newborn is at higher risk of certain diseases? A small study suggests they can

In the Lab By Megan Molteni

A new technology, based on a quirk of evolutionary biology, may be the next big thing for CRISPR

In the Lab By Megan Molteni

Discovery of rare mutation in a brain protein adds fuel to debate over cause of Alzheimer’s disease

Pharmalot By Ed Silverman

As Bluebird backpedals from Europe, small gene and cell therapy players face tough hurdles

Biotech By Damian Garde

Virtual Event: Gene therapy’s next steps

In the Lab By Megan Molteni

Scientists plumbing mysterious RNAs in the human genome find a possible treatment for an inherited disorder

Health By Claudia López Lloreda

Large study finds genetic signals that might be used to predict early menopause

Health Tech By Anissa Gardizy — Boston Globe

Deep Genomics raises $180 million to automate drug discovery

Health By Andrew Joseph

The baby was gravely ill. Rapid sequencing turned around a diagnosis in 13 hours — and pointed to a treatment

Biotech By Matthew Herper

Pacific Biosciences to buy smaller DNA sequencing firm for up to $800 million

Health By Eric Boodman

With fewer than 400 progeria patients worldwide, testing a CRISPR cure will be challenging

STAT Summit By Megan Molteni

Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too

Health By Megan Molteni

World Health Organization advisers urge global effort to regulate genome editing

In the Lab By Megan Molteni

Landmark gene therapy trial points to a wider window to alter course of rare disease

Health By Megan Molteni

Gene hunters turn up new clues to help explain why Covid-19 hits some people so hard

Health By Andrew Joseph

For people in sickle cell crisis, specialized infusion centers offer far better care than the ER, study finds

Health By Claudia López Lloreda

Researchers raise concerns about using genetic risk scores to pick ‘healthier’ embryos

In the Lab By Erika Check Hayden

Could editing the genomes of bats prevent future coronavirus pandemics? Two scientists think it’s worth a try

In the Lab By Megan Molteni

With a souped up synthetic genome, scientists make bacteria impervious to viral attack

In the Lab By Matthew Herper

Researchers claim they have sequenced the entirety of the human genome — including the missing parts

Health By Elizabeth Cooney

‘We shouldn’t leave anybody behind’: Inequities in cancer genomics undercut promise of precision medicine

Exclusive By Megan Molteni and Katie Palmer

From two unusual organ donations, scientists garner a unique trove of single-cell genetic data

Special Report By Andrew Joseph

‘It’s not a cure’: A gene therapy is opening a new chapter for children, but challenges endure

Health By Megan Molteni

With engineered proteins, scientists use optogenetics for the first time to help a blind patient see again